JK talks about being market competitive, this is what the directors of STX is getting in terms of incentive options...
http://www.strikeoil.com.au/media/2008_10_17_Notice_of_AGM_and_Explanatory_Statement.pdf
(1) There are performance hurdles such as price trading at 40c for 30 consecutive days
(2) The options are issued at a substantial premium to the share price at the time, with implied option value of 0.5c.
STX is getting 40-50mn revenue per annum, and will be increasing, with 2P net reserve of over 2MBOe and 3P of over 24MBOe. Oh, and STX will be cashflow positive for a while. So compare Ashton's performance and renumeration to those of JK's, do you really think he deserves the extra options?
618
- Forums
- ASX - By Stock
- VPE
- meeting feb 10
meeting feb 10, page-7
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VPE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online